UBS Group AG - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 30 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$26,000
+4.0%
73,109
-44.1%
0.00%
Q1 2020$25,000
-34.2%
130,822
-25.2%
0.00%
Q4 2019$38,000
+111.1%
174,990
+119.7%
0.00%
Q3 2019$18,000
-28.0%
79,657
-20.6%
0.00%
Q2 2019$25,000
+525.0%
100,334
+1089.4%
0.00%
Q1 2019$4,000
-75.0%
8,436
-79.2%
0.00%
Q4 2018$16,000
+1500.0%
40,523
+1084.5%
0.00%
Q1 2018$1,000
-99.1%
3,421
-97.9%
0.00%
Q4 2017$108,000
+440.0%
162,079
+1141.4%
0.00%
Q1 2017$20,000
+566.7%
13,056
+243.7%
0.00%
Q4 2016$3,000
-66.7%
3,799
-26.2%
0.00%
Q2 2016$9,000
+800.0%
5,147
+1177.2%
0.00%
Q2 2015$1,000
-66.7%
403
-70.2%
0.00%
Q1 2015$3,000
-62.5%
1,351
-3.8%
0.00%
Q4 2014$8,0001,4050.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders